The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $43.98

Today's change+0.40 +0.92%
Updated December 18 10:50 AM EST. Delayed by at least 15 minutes.
 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $43.98

Today's change+0.40 +0.92%
Updated December 18 10:50 AM EST. Delayed by at least 15 minutes.

Novo Nordisk A/S up (U.S.)$0.40

Novo Nordisk A/S is up today by (U.S.)$0.40 or 0.92% to (U.S.)$43.98. Shares have lost 3.59% over the last five days, but have gained 19.02% over the last year to date. This security has outperformed the S&P 500 by 12.22% during the last year.

Key company metrics

  • Open(U.S.) $43.70
  • Previous close(U.S.) $43.58
  • High(U.S.) $44.08
  • Low(U.S.) $43.66
  • Bid / Ask(U.S.) $43.97 / (U.S.) $43.99
  • YTD % change+19.02%
  • Volume461,638
  • Average volume (10-day)1,204,356
  • Average volume (1-month)1,162,874
  • Average volume (3-month)1,497,036
  • 52-week range(U.S.) $35.01 to (U.S.) $49.11
  • Beta0.96
  • Trailing P/E27.20×
  • P/E 1 year forward25.52×
  • Forward PEG2.03×
  • Indicated annual dividend(U.S.) $0.83
  • Dividend yield1.89%
  • Trailing EPS(U.S.) $1.62
Updated December 18 10:50 AM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+30.79%

Based on its net profit margin of 30.79%, Novo Nordisk A/S is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.61%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2014Q1/2014Q4/2013Q3/2013
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013Sep 30, 201309/30/2013
Revenue21,62920,34321,69820,511
Total other revenue--------
Total revenue21,62920,34321,69820,511
Gross profit17,95816,87718,29816,986
Total cost of revenue3,6713,4663,4003,525
Total operating expense12,89612,31014,34412,519
Selling / general / administrative6,3545,8917,5576,351
Research & development3,0753,1683,5662,795
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total-204-215-179-152
Operating income8,7338,0337,3547,992
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax8,9898,3017,7908,299
Income after tax6,9946,4586,0536,415
Income tax, total1,9951,8431,7371,884
Net income6,9946,4586,0536,415
Total adjustments to net income--------
Net income before extra. items6,9946,4586,0536,415
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6,9946,4586,0536,415
Inc. avail. to common incl. extra. items6,9946,4586,0536,415
Diluted net income6,9946,4586,0536,415
Dilution adjustment0------
Diluted weighted average shares2,6372,6532,6662,682
Diluted EPS excluding extraordinary itemsvalue per share2.652.432.272.39
Dividends per sharevalue per share0.000.003.350.00
Diluted normalized EPSvalue per share2.652.432.272.39